HANXBIO-B(03378): The stable price period ends, there will be no stable price actions and the oversubscribed rights issue will be invalid.

HANXBIO-B (03378) announced that the stabilization period for the global offering ended on January 17, 2026 (Saturday), which is 30 days after the deadline for submitting applications for the Hong Kong public offering. In addition, the sponsor and overall coordinator (on behalf of itself and the international underwriters) confirmed that there was no over-allotment of shares under the international offering. Therefore, the over-allotment option was not exercised and expired on January 17, 2026 (Saturday). The stabilization price operator informed the company that no stabilization actions were taken by the stabilization price operator or anyone acting on its behalf during the stabilization period.